Optimax, the UK's longest established vision correction specialist, has extended its range of implantable lenses with an advanced new addition.
The Carl Zeiss AT LARA Premium IOL receives its official launch this month, however Mr Balasupramaniam Ilango, Medical Director at Optimax, was granted early permission to trial the lens with selected patients for the purpose of publishing his findings.
Early reports indicate high levels of patient satisfaction, with fewer instances of side effects associated with Lens Exchange surgery.
The new lens builds on Optimax's reputation for early introduction of advanced lens technology, following its pre-launch offering of the AMO Symfony lens in 2014.
Optimax is the UK's longest established vision correction specialist, with clinics nationwide. Its range of procedures can treat short sight, long sight and astigmatism. Established in 1991, Optimax has experience drawn from more than 380,000 treatments. Its insistence on highly advanced laser and lens technology means that even more people can see life more clearly.
For further information, please contact: James Seton, Marketing and Communications, Optimax
Tel: +44(0)-20-7317-8639
Email: [email protected]
Site: http://www.optimax.co.uk
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...
